Opportunity

SAM #W81K0222D0018

DHA HCD West biochemical antibiotic susceptibility testing supplies modification

Buyer

Defense Health Agency

Posted

November 17, 2026

Respond By

November 18, 2026

Identifier

W81K0222D0018

NAICS

325413

DHA HCD West is modifying its biochemical antibiotic susceptibility testing requirement to address discontinued supplies and higher-than-anticipated testing demand. - Agency: Defense Health Agency (DHA), HCD West. - Opportunity: Solicitation modification under solicitation number W81K0222D0018. - Requirement: Replacement supplies for discontinued items and increased quantities for testing. - Details not provided: The notice does not identify specific products, manufacturers, vendors, part numbers, quantities, or detailed technical requirements.

Description

The purpose of this modification is to provide replacement supplies for discontinued items and provide  increased quantity due to unanticipated increase in testing. The modification also incorporates FAR clause 52.40-91 Security Prohibitions and Exclusions based on FAR 40.205(b).

View original listing